Rhumbline Advisers Adamas Pharmaceuticals, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
N/A
-36,710 Closed
0 $0
Q1 2020

May 06, 2020
SELL
N/A
-610 Reduced 1.63%
36,710 $106,000
Q4 2019

Feb 05, 2020
BUY
N/A
154 Added 0.41%
37,320 $141,000
Q3 2019

Oct 23, 2019
BUY
N/A
2,974 Added 8.7%
37,166 $190,000
Q2 2019

Aug 14, 2019
BUY
N/A
5,084 Added 17.47%
34,192 $212,000
Q1 2019

May 01, 2019
SELL
N/A
-673 Reduced 2.26%
29,108 $207,000
Q4 2018

Jan 31, 2019
BUY
N/A
9,514 Added 46.94%
29,781 $254,000
Q3 2018

Nov 07, 2018
SELL
N/A
-625 Reduced 2.99%
20,267 $406,000
Q2 2018

Aug 06, 2018
BUY
N/A
5,525 Added 35.95%
20,892 $540,000
Q1 2018

May 02, 2018
BUY
N/A
455 Added 3.05%
15,367 $367,000
Q4 2017

Feb 09, 2018
SELL
N/A
-2,441 Reduced 14.07%
14,912 $505,000
Q3 2017

Nov 06, 2017
BUY
N/A
17,353
17,353 $367,000

About Adamas Pharmaceuticals, Inc.

ADMS Quotes by TradingView
  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email